The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC).
about
Screening for prostate cancerScreening for prostate cancerClinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic diseaseIn-depth proteomic analyses of direct expressed prostatic secretions.The C-terminal fragment of prostate-specific antigen, a 2331 Da peptide, as a new urinary pathognomonic biomarker candidate for diagnosing prostate cancer.Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis.Applicabillity of noninvasive biomarkers in prostate cancer diagnosis.Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.Prostate cancer in renal transplant recipients.Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer.
P2860
Q24201690-B4A7EF1C-C1FB-4FEB-B4AC-520D685FB196Q24245476-187408B9-E2CE-4840-9B81-027A150A4123Q33449075-0A181CDE-C086-471D-A10D-3EB5BE17EB80Q33849273-1E8D6DD4-5299-493D-A4FB-F1A9B77ABB98Q35261674-41925AB7-1D15-4EA8-B0CE-74C105DB6A84Q36400527-146B6236-793A-42DA-A8D6-ED2F3AD5ED81Q38166577-63E668E2-88DB-4877-994D-964F1B36BC5AQ40001816-6708C6E3-3885-4B7F-85E0-9D7C49571E6FQ41548112-FA9DFEEF-95B1-4606-BBA9-DC1EF7A19184Q46465755-FA6E1D64-A55D-4A82-A041-72648C4ED157Q46746836-B45F942A-CC20-492D-A2C4-E054B66B483AQ46935108-73DA13D5-770D-4A58-9DAD-4D5983955FC3Q51074214-187A900D-086B-42D9-BE62-726F640B0137
P2860
The value of different screening tests in predicting prostate biopsy outcome in screening for prostate cancer data from a multicenter study (ERSPC).
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The value of different screeni ...... m a multicenter study (ERSPC).
@ast
The value of different screeni ...... m a multicenter study (ERSPC).
@en
type
label
The value of different screeni ...... m a multicenter study (ERSPC).
@ast
The value of different screeni ...... m a multicenter study (ERSPC).
@en
prefLabel
The value of different screeni ...... m a multicenter study (ERSPC).
@ast
The value of different screeni ...... m a multicenter study (ERSPC).
@en
P2093
P356
P1433
P1476
The value of different screeni ...... m a multicenter study (ERSPC).
@en
P2093
P304
P356
10.1002/PROS.20545
P577
2007-03-01T00:00:00Z